New drug combo aims to wipe out hidden myeloma after transplant

NCT ID NCT05434689

Ongoing Disease control Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jan 09, 2026 · Last updated May 25, 2026 · Updated 19 times

Summary

This study tests whether adding iberdomide (a pill) with other drugs can eliminate tiny amounts of multiple myeloma that remain after a stem cell transplant. About 80 adults who still have detectable cancer cells after transplant will receive these combinations. The goal is to achieve a deeper remission and better long-term disease control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Duke University

Durham, North Carolina, 27710, United States
Ohio State University Medical College

Columbus, Ohio, 43210, United States
Oregon Health and Science University

Portland, Oregon, 97239, United States
University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States
University of Wisconsin

Madison, Wisconsin, 53705, United States
Vanderbilt University Medical College

Nashville, Tennessee, 37232, United States

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA